{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:16Z","timestamp":1786985416611,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004742","name":"National Academy of Sciences of Ukraine","doi-asserted-by":"publisher","award":["0120U103077"],"award-info":[{"award-number":["0120U103077"]}],"id":[{"id":"10.13039\/501100004742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014413","name":"Wy\u017csza Szko\u0142a Informatyki i Zarzadzania z siedziba w Rzeszowie","doi-asserted-by":"publisher","award":["DS 503\u201307\u201301\u201327"],"award-info":[{"award-number":["DS 503\u201307\u201301\u201327"]}],"id":[{"id":"10.13039\/501100014413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2020-2022"],"award-info":[{"award-number":["2020-2022"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018227","name":"National Research Foundation of Ukraine","doi-asserted-by":"publisher","award":["2020.02\/0035"],"award-info":[{"award-number":["2020.02\/0035"]}],"id":[{"id":"10.13039\/100018227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bmc.2023.117442","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T21:36:41Z","timestamp":1691703401000},"page":"117442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pyrrolidinedione-thiazolidinone hybrid molecules with potent cytotoxic effect in squamous cell carcinoma SCC-15 cells"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4112-8815","authenticated-orcid":false,"given":"Nataliya","family":"Finiuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Kaleniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9892-437X","authenticated-orcid":false,"given":"Serhii","family":"Holota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-2187","authenticated-orcid":false,"given":"Rostyslav","family":"Stoika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3322-0080","authenticated-orcid":false,"given":"Roman","family":"Lesyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2207-1160","authenticated-orcid":false,"given":"Konrad A.","family":"Szychowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117442_b0005","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/molecules26092601","article-title":"Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?","volume":"26","author":"Szumilak","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117442_b0010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/ph15091071","article-title":"Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids","volume":"15","author":"Singh","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2023.117442_b0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","article-title":"Chemotherapy: a double-edged sword in cancer treatment","volume":"71","author":"Behranvand","year":"2022","journal-title":"Cancer Immunol Immunother: CII"},{"key":"10.1016\/j.bmc.2023.117442_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2023.117442_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy"},{"key":"10.1016\/j.bmc.2023.117442_b0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2174\/1573406417666210806094543","article-title":"Synthesis and Biological Evaluation of Novel 2-imino-4-thiazolidinones as Potential Antitumor Agents for Glioblastoma","volume":"18","author":"Campos","year":"2022","journal-title":"Med Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0035","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.3390\/ijms232113135","article-title":"4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design","volume":"23","author":"Roszczenko","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117442_b0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejmech.2019.03.024","article-title":"Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues","volume":"170","author":"de Siqueira","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0045","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jhet.3514","article-title":"Thiazolidinones: Synthesis, Reactivity, and Their Biological Applications","volume":"56","author":"Nirwan","year":"2019","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bioorg.2017.10.014","article-title":"Synthetic and medicinal perspective of thiazolidinones: A review","volume":"75","author":"Kaur Manjal","year":"2017","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-021-01523-z","article-title":"Ponesimod: First Approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2023.117442_b0060","article-title":"Synthetic strategies and medicinal perspectives of 4-thiazolidinones: Recent developments and structure\u2013activity relationship studies","author":"Chawla","year":"2022","journal-title":"J Heterocycl Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0065","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.3390\/ijms23084091","article-title":"2-{5-[(Z,2Z)-2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-oxo-2-thioxothiazolidin-3-yl}-3-methylbutanoic Acid as a Potential Anti-Breast Cancer Molecule","volume":"23","author":"Buzun","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117442_b0070","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.1038\/s41598-019-47177-6","article-title":"Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one","volume":"9","author":"Szychowski","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117442_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104557","article-title":"Research progress in biological activities of succinimide derivatives","volume":"108","author":"Zhao","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0080","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/cmdc.202000458","article-title":"Synthesis and biological evaluation of pyrazoline and pyrrolidine-2, 5-dione hybrids as potential antitumor agents","volume":"15","author":"Tilekar","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117442_b0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ejmech.2019.06.094","article-title":"Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo","volume":"179","author":"Luo","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0090","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1016\/j.bmc.2010.05.073","article-title":"Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity","volume":"18","author":"Subtel'na","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0095","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.3390\/molecules26103057","article-title":"Synthesis and Anticancer Activity Evaluation of 5-[2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-thiazolidinones","volume":"26","author":"Buzun","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117442_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114422","article-title":"Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation","volume":"238","author":"Finiuk","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tripleo.2005.07.038","article-title":"Oral squamous cell carcinoma: review of prognostic and predictive factors","volume":"102","author":"Massano","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.bmc.2023.117442_b0110","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/ijms22052252","article-title":"New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis","volume":"22","author":"Chen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117442_b0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.arcmed.2016.07.007","article-title":"Tumor Growth and Cell Proliferation Rate in Human Oral Cancer","volume":"47","author":"Gavish","year":"2016","journal-title":"Arch Med Res"},{"key":"10.1016\/j.bmc.2023.117442_b0120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archotol.129.2.219","article-title":"Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer","volume":"129","author":"de C\u00e1ssia Braga","year":"2003","journal-title":"Arch Otolaryngol-Head Neck Surg"},{"key":"10.1016\/j.bmc.2023.117442_b0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmech.2017.09.071","article-title":"Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPAR\u03b3)","volume":"141","author":"Szychowski","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0130","first-page":"601","article-title":"Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma","volume":"13","author":"Takashima","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmc.2023.117442_b0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cbi.2016.12.008","article-title":"Study of novel anticancer 4-thiazolidinone derivatives","volume":"262","author":"Szychowski","year":"2017","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2023.117442_b0140","first-page":"2.26.1","article-title":"Quantification of Lactate Dehydrogenase for Cell Viability Testing Using Cell Lines and Primary Cultured Astrocytes. Current Protocols","volume":"72","author":"Kaja","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.bmc.2023.117442_b0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117442_b0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2023.117442_b0155","unstructured":"Available from: http:\/\/lmmd.ecust.edu.cn\/admetsar2\/."},{"key":"10.1016\/j.bmc.2023.117442_b0160","unstructured":"Available from: https:\/\/admetmesh.scbdd.com\/service\/evaluation\/index."},{"key":"10.1016\/j.bmc.2023.117442_b0165","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/molecules27030894","article-title":"Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives","volume":"27","author":"Sk\u00f3ra","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117442_b0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bmc.2023.117442_b0175","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/ars.2020.8024","article-title":"Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism","volume":"33","author":"Smolkov\u00e1","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.bmc.2023.117442_b0180","doi-asserted-by":"crossref","first-page":"21267","DOI":"10.1021\/acsomega.2c02410","article-title":"Harnessing ROS-Induced Oxidative Stress for Halting Colorectal Cancer via Thiazolidinedione-Based SOD Inhibitors","volume":"7","author":"Abd Al Moaty","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2023.117442_b0185","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.2174\/09298673113209990143","article-title":"Thiazoles and thiazolidinones as antioxidants","volume":"20","author":"Geronikaki","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3325\/cmj.2016.57.151","article-title":"Putative anticancer potential of novel 4-thiazolidinone derivatives: cytotoxicity toward rat C6 glioma in vitro and correlation of general toxicity with the balance of free radical oxidation in rats","volume":"57","author":"\u041aobylinska","year":"2016","journal-title":"Croat Med J"},{"key":"10.1016\/j.bmc.2023.117442_b0195","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3325\/cmj.2017.58.150","article-title":"Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells","volume":"58","author":"\u041aobylinska","year":"2017","journal-title":"Croat Med J"},{"key":"10.1016\/j.bmc.2023.117442_b0200","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","article-title":"Secondary necrosis: the natural outcome of the complete apoptotic program","volume":"584","author":"Silva","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2023.117442_b0205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1677\/erc.1.01182","article-title":"Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones","volume":"13","author":"Weng","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bmc.2023.117442_b0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2008.08.008","article-title":"PPARgamma-independent antitumor effects of thiazolidinediones","volume":"276","author":"Wei","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2023.117442_b0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-016-9665-x","volume":"31","author":"W\u00f3jtowicz","year":"2017","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bmc.2023.117442_b0220","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1128\/MCB.00915-07","article-title":"NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis","volume":"27","author":"Shin","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmc.2023.117442_b0225","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1164\/rccm.200907-1047OC","article-title":"Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice","volume":"182","author":"Cho","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bmc.2023.117442_b0230","doi-asserted-by":"crossref","first-page":"18504","DOI":"10.1074\/jbc.RA119.009282","article-title":"Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPAR\u03b3 for proteasomal degradation","volume":"294","author":"Dou","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/antiox11020227","article-title":"AHR and NRF2 in Skin Homeostasis and Atopic Dermatitis","volume":"11","author":"Edamitsu","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bmc.2023.117442_b0240","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mc.22615","article-title":"ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells","volume":"56","author":"Bao","year":"2017","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.bmc.2023.117442_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737776","article-title":"PPAR-\u03b3 Modulators as Current and Potential Cancer Treatments","volume":"11","author":"Chi","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2023.117442_b0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-020-03689-8","article-title":"The influence of conjugated linoleic acid on the expression of peroxisome proliferator-activated receptor-\u03b3 and selected apoptotic genes in non-small cell lung cancer","volume":"466","author":"S\u0142owikowski","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bmc.2023.117442_b0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pros.23928","article-title":"Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms","volume":"80","author":"Elix","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.bmc.2023.117442_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106075","article-title":"New 4-thiazolidinone-based molecules Les-2769 and Les-3266 as possible PPAR\u03b3 modulators","volume":"128","author":"Bar","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117442_b0265","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.acthis.2016.05.002","article-title":"Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer","volume":"118","author":"Jur\u00edkov\u00e1","year":"2016","journal-title":"Acta Histochem"},{"key":"10.1016\/j.bmc.2023.117442_b0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2023.117442_b0275","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/ijms20040987","article-title":"Four Major Channels Detected in the Cytochrome P450 3A4: A Step toward Understanding Its Multispecificity","volume":"20","author":"Benkaidali","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117442_b0280","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/mp400450m","article-title":"ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates","volume":"11","author":"Li","year":"2014","journal-title":"Mol Pharm"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623002900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623002900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:24:09Z","timestamp":1760837049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623002900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":56,"alternative-id":["S0968089623002900"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117442","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrrolidinedione-thiazolidinone hybrid molecules with potent cytotoxic effect in squamous cell carcinoma SCC-15 cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117442"}}